Endogenous Bufadienolides, Fibrosis and Preeclampsia
Joint Authors
Agalakova, Natalia Ivanovna
Reznik, Vitaliy A.
Kashkin, Vladimir A.
Adair, C. David
Bagrov, Alexei Y.
Source
Cardiology Research and Practice
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-12-12
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Frequency of preeclampsia has no tendency to decrease, and it still takes the leading position in the structure of maternal mortality and morbidity worldwide.
In this review, we present the “fibrotic concept” of the etiology and pathogenesis of preeclampsia which involves system consisting of Na/K-ATPase and its endogenous ligands including marinobufagenin.
New therapy of preeclampsia includes modulation of the Na/K-ATPase system by immunoneutralization of the marinobufagenin and use of mineralocorticoid antagonists which are capable to impair marinobufagenin-Na/K-ATPase interactions.
American Psychological Association (APA)
Reznik, Vitaliy A.& Kashkin, Vladimir A.& Agalakova, Natalia Ivanovna& Adair, C. David& Bagrov, Alexei Y.. 2019. Endogenous Bufadienolides, Fibrosis and Preeclampsia. Cardiology Research and Practice،Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1146003
Modern Language Association (MLA)
Reznik, Vitaliy A.…[et al.]. Endogenous Bufadienolides, Fibrosis and Preeclampsia. Cardiology Research and Practice No. 2019 (2019), pp.1-7.
https://search.emarefa.net/detail/BIM-1146003
American Medical Association (AMA)
Reznik, Vitaliy A.& Kashkin, Vladimir A.& Agalakova, Natalia Ivanovna& Adair, C. David& Bagrov, Alexei Y.. Endogenous Bufadienolides, Fibrosis and Preeclampsia. Cardiology Research and Practice. 2019. Vol. 2019, no. 2019, pp.1-7.
https://search.emarefa.net/detail/BIM-1146003
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1146003
